Ph.D., President and CEO, Claritas Genomics
Dr. Milos, a pioneer at the interface of genomics and medicine, leads Claritas in its mission to serve children affected with complex genetic disorders by providing timely and accurate results, resolving families’ long search for answers, combining clinical expertise of the world’s best pediatric specialists with innovative platform solutions, to improve pediatric precision care. Previously, Patrice was the Boston Site Head for Pfizer’s Centers of Therapeutic Innovation, establishing academic partnerships for novel mechanisms to treat human disease. Dr. Milos previously served as CSO for Helicos BioSciences, Cambridge, MA and as Executive Director at Pfizer leading pharmacogenomics, proteomics, metabonomics, DNA sequencing, RNA profiling, and translational biomarkers applied across the Pfizer portfolio from early discovery into the marketplace.
Session: Diagnosis & Management of Rare Disease
We are at a major inflection point in our ability to use clinical genomic information to diagnosis and manage thousands of rare diseases, yet the ability to ensure patient access to this information and innovative science remains unrealized due to an array of complex barriers. With 30 million patients in the U.S. and 300 million around the globe living with the burden of a rare disease, this unmet medical need is substantial. The panel includes a variety of stakeholders involved in finding innovative solutions to remove these barriers for patients and their healthcare providers in today’s fragmented medical care system.